Compositions and methods for quantification of serum glycoproteins

(19)

(11)

EP 2 302 393 A8

(12)	CORRECTED EUROPEAN PATENT APPLICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 A1)

(48)	Corrigendum issued on:
	03.08.2011 Bulletin 2011/31

(43)	Date of publication:
	30.03.2011 Bulletin 2011/13

(21)	Application number: 10012636.6

(22)	Date of filing: 20.05.2005

(51)

International Patent Classification (IPC):

G01N 33/68^(2006.01)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

21.05.2004 US 573593

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	09153474.3 / 2093569
	05751819.3 / 1766412

(71)	Applicant: The Institute for Systems Biology
	Seattle, WA 98103-1299 (US)

(72)	Inventors:
	Aebersold, Rudolph H. 8049 Zürich (CH) Zhang, Hui Seattle, WA 98115 (US)

(74)	Representative: UEXKÜLL & STOLBERG
	Patentanwälte Beselerstrasse 4 22607 Hamburg 22607 Hamburg (DE)


	Remarks:
	The complete document including Reference Tables and the Sequence Listing can be downloaded from the EPO website


	Remarks:
	Claims filed after the date of filing of the application/after the date of receipt of the divisional application (Rule 68(4)EPC)


	Remarks:
	This application was filed on 30-09-2010 as a divisional application to the application mentioned under INID code 62.

(54)	Compositions and methods for quantification of serum glycoproteins

(57) The invention provides compositions and methods for identifying and/or quantifying glycopolypeptides from human serum or plasma. The compositions and methods include a plurality of standard peptides containing glycosylation sites determined for human serum/plasma proteins.